AGP Picks
View all

Connecticut Health Digest: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Connecticut Health Digest.

Press releases published on June 4, 2026

Confidia Health Institute Expands Integrated Approach to Preventive and Wellness Care
Project Farma Expands PMIS Offering with Oracle Primavera Cloud to Address Growing Pharma Capital Project Complexity
Aspire Living & Learning Strengthens Its Board with the Appointment of John Barrett
DEA to Convene Inaugural Fentanyl Free America Summit at CADCA’s 25th Annual Mid-Year Training Institute
Canada’s Trail Sector Unites in Winnipeg to Chart a Path for the Future
Moving Beyond the Binder: ChairPulse Debuts AI-Powered Operations Layer for Dental Practices
Seven Arrows Recovery Expands Public Education Efforts Around Forward-Facing, Nervous System Centred Addiction Treatment
Allsup Highlights Pancreatic Cancer Research And Importance Of Timely SSDI Applications
Centre for Neuro Skills’ Chris Persel Receives First-Ever Enduring Contributions Award
The Pennant Group and Hartford HealthCare Expand Collaboration to Advance Home-Based Care in Connecticut
Genovyn Appoints Industry Veterans Sammy Bell as Chief Scientific Officer and Jim Edinger as Chief Development Officer to Accelerate AI-Enabled Therapeutic Discovery and Development
Sienna Senior Living Inc. Announces Voting Results From Annual Meeting
Oncovita presents promising preclinical data on MVdeltaC, a novel onco-immunotherapy at EACR, 8-11 June 2026, in Budapest
Cogensus Receives Further Investment from Caduceus Capital Partners
Nika Pharmaceuticals, Inc. (OTCQB: NIKA) June 2026 Update
Adam Ferrari Health Science Scholarship Application Deadline Approaches for 2026 Cycle
NMDP Celebrates Milestone 150,000th Transplant Representing Nearly Four Decades of Hope, Innovation and Second Chances
Nexalin Technology Announces Issuance of U.S. Patent Covering Dynamic Frequency Stimulation for Anxiety, Depression and Insomnia
MAIA Biotechnology Reports Strong Enrollment and Dosing Momentum in Pivotal Phase 3 Non-Small Cell Lung Cancer Trial
Baba Selected for CMS ACCESS Model Across All Four Clinical Tracks

Share this page:

Sign up for:

Connecticut Health Digest

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.